The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria
Authors
Keywords
-
Journal
Biomolecules
Volume 9, Issue 8, Pages 298
Publisher
MDPI AG
Online
2019-07-24
DOI
10.3390/biom9080298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug
- (2019) Andile H. Ngwane et al. IUBMB LIFE
- Mitochondrial metabolism promotes adaptation to proteotoxic stress
- (2019) Peter Tsvetkov et al. Nature Chemical Biology
- Elesclomol restores mitochondrial function in genetic models of copper deficiency
- (2018) Shivatheja Soma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Mitochondrial Complex(I)ty of Cancer
- (2017) Félix A. Urra et al. Frontiers in Oncology
- A phase I study of elesclomol sodium in patients with acute myeloid leukemia
- (2016) David Hedley et al. LEUKEMIA & LYMPHOMA
- Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents
- (2015) Josephine Modica-Napolitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection
- (2015) Paolo Bernardi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol
- (2013) Shoujun Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells
- (2012) Marco Spinazzi et al. Nature Protocols
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
- (2012) Ronald K. Blackman et al. PLoS One
- In Vitro Effect of Copper Chloride Exposure on Reactive Oxygen Species Generation and Respiratory Chain Complex Activities of Mitochondria Isolated from Broiler Liver
- (2011) Rongsheng Su et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- The Role of Mitochondria in Reactive Oxygen Species Metabolism and Signaling
- (2010) Anatoly A. Starkov Annals of the New York Academy of Sciences
- Reactive oxygen species-dependent signaling regulates cancer
- (2009) Frank Weinberg et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- N′1,N′3-Dimethyl-N′1,N′3-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS)
- (2009) Medhi Wangpaichitr et al. Cancers
- Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species
- (2008) Romana Fato et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
- (2008) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started